If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with Boston Globe Media Group

9 Oct 2015 07:00

RNS Number : 7432B
Phorm Corporation Limited
09 October 2015
 

9 October 2015

 

Phorm Corporation Limited

("Phorm" or the "Company")

Agreement with Boston Globe Media Group

Phorm (AIM: PHRM), an advertising-technology company, is pleased to announce, further to its interim results released on 30 September 2015, that Boston Globe Media Group ("Boston Globe"), a leading U.S. digital media group, is implementing the Company's targeted advertising technology on its digital properties.

 

Phorm's cutting-edge Machine-Learning Artificial Intelligence ("AI") technology makes it easier and more efficient for publishers (and other sellers of advertisements) to identify and target specific audiences and extend audience reach to ultimately achieve more successful advertising campaigns. The Company's proprietary technology also provides unrivaled insight into digital advertising supply and demand dynamics such that publishers can regain more control of their advertising inventory.

 

Recognising the potential value and benefits of Phorm's software platform, Boston Globe will implement Phorm' technology across its digital properties to seek and achieve increased advertising sales and performance as well as optimised inventory control.

 

Boston Globe, through its developing relationship with Phorm, will continue to seek to extend its circa 4 - 5 million unique visitors per month, increase its advertising revenues through new sources, and optimise the revenue potential of all third party partnerships that it is working with, including Phorm.

 

Commenting on Boston Globe's decision to implement Phorm's platform, Pete Doucette, VP of Consumer Sales & Marketing, said:

 

"We are always looking to increase our revenue and margin, and engage with new users across our various websites and media channels. Phorm's technology will enable us to identify users in a deeper and more meaningful manner during their consumer journey with us and other sites, with an overarching objective of increasing our potential share of advertising spend."

 

Phorm's CEO, Timothy Smith, added:

 

"We're most energised and excited to be working with such a nationally esteemed brand as the Boston Globe, which is innovating through the use of technology. We are looking forward to demonstrating the power of our technology software platform and contributing to Pete and his team's enhanced understanding of their audience, delivering users more efficiently and recruiting new users of Boston Globe's content."

 

 

-Ends-

For further information please contact: 

Phorm Corporation Limited
Timothy Smith (Chief Executive Officer) +44 (0)20 33976001

 

Mirabaud Securities LLP (Broker) +44 (0)20 7321 2508

Jason Woollard 

Peter Krens

 

Strand Hanson Limited (Nominated Adviser) +44 (0)20 7409 3494

James Harris Matthew Chandler James Dance

 

 

About Phorm

Phorm is a global advertising-technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's industry leading technology enables its Internet Service Provider ("ISP") and other partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

 

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

 

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

 

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADDBDGBBGBGUI
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.